Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

SELL
$12.46 - $15.48 $17,531 - $21,780
-1,407 Reduced 10.57%
11,903 $151,000
Q2 2023

Jul 19, 2023

SELL
$13.28 - $15.96 $36,825 - $44,257
-2,773 Reduced 17.24%
13,310 $187,000
Q1 2023

May 12, 2023

BUY
$14.26 - $22.1 $56,526 - $87,604
3,964 Added 32.71%
16,083 $248,000
Q4 2022

Feb 10, 2023

SELL
$14.85 - $19.04 $12,117 - $15,536
-816 Reduced 6.31%
12,119 $199,000
Q3 2022

Nov 03, 2022

BUY
$12.38 - $20.23 $160,135 - $261,675
12,935 New
12,935 $239,000
Q4 2021

Feb 10, 2022

SELL
$7.7 - $37.13 $50,019 - $241,196
-6,496 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$26.46 - $37.15 $171,884 - $241,326
6,496 New
6,496 $221,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.